Hims & Hers Health, Inc. (HIMS) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Hims & Hers Health, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.236 Hello, and thank you for standing by. My name is Tiffany, and I will be your conference 00:00:05.236 -- 00:00:10.361 operator today. At this time, I would like to welcome everyone to 00:00:10.361 -- 00:00:15.946 the HIMSS and HERS second quarter 2025 earnings call. 00:00:15.946 -- 00:00:20.951 All lines have been placed on mute to prevent any background noise. 00:00:20.951 -- 00:00:25.575 After the speaker's remarks, there will be a question and answer session. 00:00:25.575 -- 00:00:30.614 If you would like to ask a question during that time, Simply press star, then 00:00:30.614 -- 00:00:33.597 the number one on your telephone keypad. 00:00:33.597 -- 00:00:39.083 I would now like to turn the call over to Bill Newby, head of investor relations. 00:00:39.083 -- 00:00:42.364 Bill, please go ahead. 00:00:42.867 -- 00:00:46.711 Good afternoon, everyone, and welcome to the HIMS and HERS Health second quarter 2025 00:00:46.711 -- 00:00:51.135 earnings call. Today, after the market closed, we released this quarter's shareholder 00:00:51.135 -- 00:00:55.898 letter, a copy of which you can find on our website at investors.hims.com. 00:00:56.731 -- 00:01:00.474 On the call with me today is Andrew Dudum, our co-founder and chief executive officer, 00:01:00.474 -- 00:01:06.998 Yemi Okupe, our chief financial officer, and our new chief technology officer, Mo El-Shanawi. 00:01:07.000 -- 00:01:10.383 Before I hand it over to Andrew, I need to remind you of legal safe harbor and cautionary 00:01:10.383 -- 00:01:14.947 declarations. Certain statements and projections of future results made in this presentation 00:01:14.947 -- 00:01:18.991 constitute forward-looking statements that are based on, among other things, our current 00:01:18.991 -- 00:01:2...